Senior insider sale
XENON PHARMACEUTICALS INC. — senior position signals high conviction
$63.1K
1.19K shares
What this filing means
CANNON GILLIAN plans to sell 1.19K shares of XENON PHARMACEUTICALS INC. valued at approximately $63.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2026ACC: 0001950047-26-005712
1.19K
Shares to sell
$63.1K
Approx. market value
1.19K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/31/2026
1.19KTotal acquired1.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/31/2026 | Restricted Stock Units N/A | 1.19K | — |
| Total | 1.19K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.19K
Market value
$63.1K
6/5/2026
Total
Units
1.19K
Value
$63.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/5/2026 | 1.19K | $63.1K | NASDAQ | Planned |
| Total | 1.19K | $63.1K | ||